Prix Galien USA Honors Innovation in Science and Biotech ...(21 candidates are: Best Pharmaceutic...),Health

Best Pharmaceutical Product:

• Novartis Oncology, GLEEVEC(R) -- By targeting the specific cancer-causing molecules in the body, GLEEVEC(R)( )attacks cancerous cells while sparing healthy cells and the immune system.
  

Best Biotechnology Product:

• Amgen, Nplate(R) -- A thrombopoietin receptor agonist used in the treatment of thrombocytopenic purpura by increasing platelet counts without affecting the immune system.
• GlaxoSmithKline, PROMACTA(R) -- Approved for the treatment of thrombocytopenia, the product increases platelet levels and does not inhibit normal antibody production.
  

Best Medical Technology:

• Veridex, CellSearch(R) CTC Test -- The device is used to enumerate tumor cells in whole blood, making it the first of its kind that is capable of reliably isolating and identifying cells in patients with metastatic breast, colorectal or prostate cancer.
  

The Prix Galien Award (www.prix-galien-usa.com) recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines, and is considered the equivalent to the Nobel Prize. Prix Galien was first established in 1970 by French pharmacist Roland Mehl and was inaugurated in the United States in September 2007. The Prix Galien USA awards committee of 11 individuals includes seven Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journals.

SOURCE Vanguard Communications